RT-qPCR analysis subsequently confirmed the high proliferation level of GBM cells through the mRNA expression level of PCNA. In addition, the expression of CD276 was found to be correlated with the sensitivity of GBM to chemotherapy drugs. The gene discussed is CD276; the disease is glioblastoma.